Engaging with Bispecific T-Cell Engagers
Last Updated: May 16, 2025
An overview of how these agents’ function, their dosing schedules, notable side effects, and the Risk Evaluation and Mitigation Strategies (REMS) requirements for certain agents.
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Putting Bispecific T-Cell Engagers into Action
Last Updated: 06/23/2025
Clearing Up Confusion Around “Bispecific Antibodies”
Last Updated: 06/23/2025
Up Close with Teclistamab
Last Updated: 06/23/2025
Up Close with Tebentafusp
Last Updated: 06/23/2025
Treatment Discussion Guides
PQI Podcast
Treatment Support Kit
PQI Podcast
Medically Integrated Oncology Treatment Discussion Guide
Last Updated: 06/23/2025
S8 Bonus Eps 2: Inside ASCO 2025
Author: Ginger Blackmon, PharmD | Kelly Brunk, PharmD, BCOP
Last Updated: 06/23/2025
Treatment Support Kit: Mirdamentinib
Last Updated: 06/23/2025
S8 E15: Supporting Survivors at Work
Author: Ginger Blackmon, PharmD | Rebecca Nellis, MPP
Last Updated: 06/23/2025